ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 5443
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
VOTUBIA 3MG TBL SUS 30X1
0194700 EU/1/11/710/012 votubia.pdf votubia.pdf L01EG02 R
VOTUBIA 3MG TBL SUS 100X1
0194701 EU/1/11/710/013 votubia.pdf votubia.pdf L01EG02 R
VOTUBIA 5MG TBL SUS 30X1
0194702 EU/1/11/710/014 votubia.pdf votubia.pdf L01EG02 R
VOTUBIA 10MG TBL NOB 30X1
0168460 EU/1/11/710/006 votubia.pdf votubia.pdf L01EG02 R
VOTUBIA 5MG TBL NOB 100X1
0168459 EU/1/11/710/005 votubia.pdf votubia.pdf L01EG02 R
VOTUBIA 5MG TBL SUS 100X1
0194703 EU/1/11/710/015 votubia.pdf votubia.pdf L01EG02 R
VOTUBIA 2,5MG TBL NOB 100X1
0168457 EU/1/11/710/003 votubia.pdf votubia.pdf L01EG02 R
VOTUBIA 5MG TBL NOB 30X1
0168458 EU/1/11/710/004 votubia.pdf votubia.pdf L01EG02 R
VUMERITY 231MG CPS ETD 360(3X120)
0255277 EU/1/21/1585/002 vumerity.pdf vumerity.pdf L04AX09 R
VUMERITY 231MG CPS ETD 120
0255276 EU/1/21/1585/001 vumerity.pdf vumerity.pdf L04AX09 R
VYVGART 20MG/ML INF CNC SOL 1X20ML
0268132 EU/1/22/1674/001 vyvgart.pdf vyvgart.pdf L04AA R
VYXEOS LIPOSOMAL 44MG/100MG INF PLV CSL 1
0238215 EU/1/18/1308/001 vyxeoslipo.pdf vyxeoslipo.pdf L01XY01 R
VYXEOS LIPOSOMAL 44MG/100MG INF PLV CSL 5
0238217 EU/1/18/1308/003 vyxeoslipo.pdf vyxeoslipo.pdf L01XY01 R
VYXEOS LIPOSOMAL 44MG/100MG INF PLV CSL 2
0238216 EU/1/18/1308/002 vyxeoslipo.pdf vyxeoslipo.pdf L01XY01 R
WELDININ 200MG TBL FLM 112 KAL
0264395 44/ 205/20-C weldinin.pdf weldinin.pdf L01EX02 R
WELDININ 200MG TBL FLM 112
0248844 44/ 205/20-C weldinin.pdf weldinin.pdf L01EX02 R
XAGRID 0,5MG CPS DUR 100
0028369 EU/1/04/295/001 xagrid.pdf xagrid.pdf L01XX35 R
XALKORI 250MG CPS DUR 60
0193649 EU/1/12/793/004 xalkori.pdf xalkori.pdf L01ED01 R
XALKORI 200MG CPS DUR 60
0193647 EU/1/12/793/002 xalkori.pdf xalkori.pdf L01ED01 R
XALKORI 250MG CPS DUR 60
0193648 EU/1/12/793/003 xalkori.pdf xalkori.pdf L01ED01 R

‹‹ ‹ 100 200 220 230 240 250 260 261 262 263 264 265 266 267 268 269 270 271 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 29. November 2022 at 00:09
Last update of price and payment data: 1. November 2022 at 00:09